-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) is an inflammatory disease of the gastrointestinal tract characterized by alternating periods of remission and relapse.
Crohn's disease (CD) is an inflammatory disease of the gastrointestinal tract characterized by alternating periods of remission and relapse.
A total of 677 patients were included in this study.
The study found that: Fecal calprotectin less than 250 mg/kg at week 6 showed a significant and accurate ability to predict ER at week 52 (AUC 0.
In conclusion, this study shows that the fecal calprotectin level of patients with CD at week 6 <250 mg/kg can predict the long-term endoscopic mucosal healing in the future, and may be more beneficial than the improvement of clinical symptoms.
In conclusion, this study shows that the fecal calprotectin level of patients with CD at week 6 <250 mg/kg can predict the long-term endoscopic mucosal healing in the future, and may be more beneficial than the improvement of clinical symptoms.
Original source:
Neeraj Narula.
oup.
Leave a message here
